Effects of Weight Loss on Obstructive Sleep Apnea Severity. Ten-Year Results of the Sleep AHEAD Study:

Samuel T. Kuna, David M. Reboussin, Elsa S. Strotmeyer, Richard P. Millman, Gary Zammit, Michael P. Walkup, Thomas A. Wadden, Rena R. Wing, F. Xavier Pi-Sunyer, Adam P. Spira, Gary D. Foster, and the Sleep AHEAD Research Subgroup of the Look AHEAD Research Group

28 July, 2020

NZ Respiratory Research Review Issue 185

Age and Sex Disparities in Adherence to CPAP:

Sanjay R. Patel, MD Jessie P. Bakker, PhD Christy J. Stitt, MS Mark S. Aloia, PhD S. Mehdi Nouraie, PhD

17 July, 2020

NZ Respiratory Research Review Issue 185

Designer Receptors Exclusively Activated by Designer Drugs Approach to Treatment of Sleep-disordered Breathing:

Thomaz Fleury Curado, Huy Pho, Carla Freire, Mateus R. Amorim, Jordi Bonaventura, Lenise J. Kim, Rachel Lee, Meaghan E. Cabassa, Stone R. Streeter, Luiz G. Branco, Luiz U. Sennes, Kenneth Fishbein, Richard G. Spencer, Alan R. Schwartz, Michael J. Brennick, Michael Michaelides, David D. Fuller, and Vsevolod Y. Polotsky

16 July, 2020

NZ Respiratory Research Review Issue 185

Impact of a Multimodal Telemonitoring Intervention on CPAP Adherence in Symptomatic OSA and Low Cardiovascular Risk:

Renaud Tamisier, MD, PhD Erika Treptow, MD, PhD Marie Joyeux-Faure, PharmD, PhD Patrick Levy, MD, PhD Marc Sapene, MD Meriem Benmerad, MSc Sebastien Bailly, PharmD, PhD Yves Grillet, MD Bruno Stach, MD Jean-François Muir, MD, PhD Hervé Pegliasco, MD Jean-Louis Pépin, MD, PhD on behalf of theOPTISAS trial Investigators

4 July, 2020

NZ Respiratory Research Review Issue 185

Who May Benefit From Diuretics in OSA?:

Bruno Revol, PharmD Ingrid Jullian-Desayes, PharmD, PhD Sébastien Bailly, PharmD, PhD Renaud Tamisier, MD, PhD Yves Grillet, MD Marc Sapène, MD Marie Joyeux-Faure, PharmD, PhD Jean-Louis Pépin, MD, PhD on behalf of theOSFP National French Registry Scientific Council

28 February, 2020

NZ Respiratory Research Review Issue 185

Obstructive sleep apnoea:

Neill, A.

6 November, 2015

This presentation describes key clinical features of OSA, its prevalence, ethnic and geographical distribution in New Zealand, disease burden, societal cost, and the cost effectiveness of current treatments. Presented to Respiratory Conference New Zealand in November 2015.

Obstructive sleep apnoea in adults:

Best Practice Advocacy Centre New Zealand.

30 November, 2012

Obstructive sleep apnoea is reported to affect 4% of adult males and 2% of adult females. In New Zealand, it is twice as common in Māori adults males compared to non-Māori.

Ethnic disparities in CPAP adherence in New Zealand: Effects of socioeconomic status, health literacy and self-efficacy:

Bakker, J., O’Keeffe, K., Neill, A., & Campbell, A.

30 April, 2011

This study investigated the influence of ethnicity on adherence with continuous positive airway pressure (CPAP) in a sample of 126 New Zealand patients. The authors concluded that disparity in CPAP adherence demonstrated between Māori and non-Māori can be explained in part by lower education levels and socioeconomic status.

Societal costs of obstructive sleep apnoea syndrome.:

Gander, P., Scott, G., Mihaere, K., & Scott, H.

27 August, 2010

Aim: To estimate the societal costs of obstructive sleep apnoea syndrome (OSAS) in New Zealand and develop a simulation tool to evaluate treatment options.

Obstructive sleep apnea in New Zealand adults: Prevalence and risk factors among Māori and non-Māori. :

Mihaere, K., Harris, R., Gander, P., Reid, P., Purdie, G., Robson, B., et al.

31 July, 2009

Study Objectives: Examine the distribution of symptoms and risk factors, and estimate the prevalence of obstructive sleep apnea (OSA) among Māori and non-Māori New Zealanders.